| Literature DB >> 34970430 |
Thomas Edward Conley1, Joseph Fiske1, Sreedhar Subramanian1.
Abstract
Acute severe ulcerative colitis (ASUC) is a medical emergency which is associated with significant morbidity and a mortality rate of 1%. ASUC requires prompt recognition and treatment. Optimal management includes admission to a specialist gastrointestinal unit and joint management with colorectal surgeons. Patients need to be screened for concomitant infections and thromboprophylaxis should be administered to mitigate against the elevated risk of thromboembolism. Corticosteroids are still the preferred initial medical therapy but approximately 30%-40% of patients fail steroid therapy and require rescue medical therapy with either infliximab or cyclosporine. Emergency colectomy is required in a timely manner for patients who fail rescue medical therapy to minimise the risk of adverse post-operative outcomes. We discuss current and emerging evidence in the management of ASUC and outline management approaches for clinicians involved in managing ASUC. © Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.Entities:
Keywords: colonic diseases; inflammatory bowel disease; infliximab; ulcerative colitis
Year: 2021 PMID: 34970430 PMCID: PMC8666866 DOI: 10.1136/flgastro-2020-101710
Source DB: PubMed Journal: Frontline Gastroenterol ISSN: 2041-4137